Rajesh is Vice President – Research & Development at Sai Life Sciences Ltd which is a fully integrated global CDMO, known for providing Discovery, Development and Manufacturing solutions, for New Chemical Entities (NCE).
Rajesh has 29 years of techno-commercial experience including P&L responsibility for CRAMS, Global R&D and scale up – commercialization of APIs, project management, customer relationship management (CRM), strategic planning and execution, due diligence – M&A and integration.
Rajesh has worked for some of the top Indian pharmaceutical organizations including Piramal Healthcare, IPCA, GVK Biosciences and Cadila Pharma before joining Sai Life Sciences.
Intelligent Lab Design: A competitive advantage for India’s growing CDMO industry
Indian CDMOs are poised to play a formidable role in the global CDMO market that is projected to be US$ 80 Billion by 2020. A critical factor in their success is delivery to the highest expectations of productivity and safety, not just from regulators but from their large pharma innovator customers as well. Intelligent lab designs with ergonomic work flows, incorporating modular features and tools, can provide the crucial competitive edge. This requires close collaboration between users and lab designers from an ideation stage itself. Is India ready to build such world-class laboratories to inspire the world?